Consistent with the concept that IPF patients have activated lymphocyte profiles, higher levels of CD4 cells (>10% of total peripheral blood) or increases in CD8 cells >2% in the peripheral blood marked patients at risk of functional decline. The gene discussed is CD8A; the disease is idiopathic pulmonary fibrosis.